Chemical compound
Pharmaceutical compound
Tolgabide (INN; development code SL-81.0142) is a drug which was patented by Synthélabo as an anticonvulsant but was never marketed.[1] It is an analogue of progabide and acts similarly to it as a prodrug of GABA, and therefore as an indirect agonist of the GABA receptors.[1][2]
See also
References
- ^ a b Triggle DJ (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
- ^ “The use of common stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances” (PDF). 2002.[dead link]
| Ionotropic |
| ||||
|---|---|---|---|---|---|
| Metabotropic |
| ||||